Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Mallinckrodt
QuintilesIMS
Argus Health
Merck
Deloitte
Cipla
Citi
UBS

Generated: April 25, 2018

DrugPatentWatch Database Preview

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Atovaquone And Proguanil Hydrochloride, and when can generic versions of Atovaquone And Proguanil Hydrochloride launch?

Atovaquone And Proguanil Hydrochloride is a drug marketed by Glenmark Generics and Mylan Pharms Inc and is included in two NDAs.

The generic ingredient in ATOVAQUONE AND PROGUANIL HYDROCHLORIDE is atovaquone; proguanil hydrochloride. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.
Drug patent expirations by year for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Pharmacology for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Synonyms for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
156879-69-5
Atovaquone proguanil combination
Atovaquone and proguanil
Atovaquone mixture with chloroguanide
Atovaquone mixture with proguanil
Atovaquone mixture with proguanil HCl
Atovaquone mixture with proguanil hydrochloride
Atovaquone-proguanil hydrochloride mixt
Imidodicarbonimidic diamide, N-(4-chlorophenyl)-N'-(1-methylethyl)-, monohydrochloride, mixt. with 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione
LS-187852
Proguanil hydrochloride - atovaquone mixt.
SCHEMBL2527023

US Patents and Regulatory Information for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics ATOVAQUONE AND PROGUANIL HYDROCHLORIDE atovaquone; proguanil hydrochloride TABLET;ORAL 091211-002 Apr 6, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc ATOVAQUONE AND PROGUANIL HYDROCHLORIDE atovaquone; proguanil hydrochloride TABLET;ORAL 202362-002 May 27, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics ATOVAQUONE AND PROGUANIL HYDROCHLORIDE atovaquone; proguanil hydrochloride TABLET;ORAL 091211-001 Jan 12, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc ATOVAQUONE AND PROGUANIL HYDROCHLORIDE atovaquone; proguanil hydrochloride TABLET;ORAL 202362-001 May 27, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Merck
Farmers Insurance
Cipla
Citi
Argus Health
McKesson
Boehringer Ingelheim
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.